ESSA Pharma(EPIX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EPIX ESSA Pharma

Pre-Market Trading 03-26 06:50:31 EDT

1.55

-0.01

-0.64%

High1.59	Low1.55	Vol82.17K
Open1.59	D1 Closing1.56	Amplitude2.56%
Mkt Cap68.80M	Tradable Cap43.65M	Total Shares44.39M
T/O127.98K	T/O Rate0.29%	Tradable Shares28.16M
P/B0.58	ROE-23.98%	EPS-0.70
52wk High9.23	52wk Low1.40	P/E-2.21
Dividend0.00	Div.Yield0.00	ROA-17.09%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"EPIX","market":"US","secType":"STK","nameCN":"ESSA Pharma","latestPrice":1.55,"timestamp":1742932800000,"preClose":1.56,"halted":0,"volume":82165,"delay":0,"floatShares":28160872,"shares":44388550,"eps":-0.701604,"marketStatus":"Pre-Market Trading","change":-0.01,"latestTime":"03-26 06:50:29 EDT","open":1.59,"high":1.59,"low":1.55,"amount":127982.34029,"amplitude":0.025641,"askPrice":1.91,"askSize":200,"bidPrice":1.42,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.701604,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1742995800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1436414400000,"exchange":"NASDAQ","adjPreClose":1.55,"postHourTrading":{"tag":"盘后","latestPrice":1.56,"preClose":1.55,"latestTime":"17:23 EDT","volume":187,"amount":291.713,"timestamp":1742937813972},"volumeRatio":1.2789043430793157,"impliedVol":2.5236,"impliedVolPercentile":0.9679},"requestUrl":"/m/hq/s/EPIX","defaultTab":"news","newsList":[{"id":"2520453918","title":"EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520453918","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520453918?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:48","pubTimestamp":1742471315,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against ESSA Pharma, Inc. ($EPIX) by Levi & Korsinsky on January 24, 2025. The plaintiffs (shareholders)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/epix-lawsuit-alert-class-action-lawsuit-against-essa-pharma-inc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/epix-lawsuit-alert-class-action-lawsuit-against-essa-pharma-inc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","EPIX","ESSA","BK4195","BK4139"],"gpt_icon":0},{"id":"2517562881","title":"Press Release: ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS","url":"https://stock-news.laohu8.com/highlight/detail?id=2517562881","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517562881?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 20:00","pubTimestamp":1741262400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada, March 6, 2025. SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada, March 6, 2025 /PRNewswire/ - ESSA Pharma Inc.  , a pharmaceutical company that, prior to the discontinuation of its clinical trials and development programs, has been focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on March 5, 2025 .At the Meeting, the shareholders of the Company  resolved to set the number of directors of the Company at seven and re-elected to the board of directors, by ordinary resolution passed by ballot vote, David R. Parkinson, Richard M. Glickman, Franklin M. Berger, Scott Requadt, Marella Thorell, Alex Martin and Sandy Zweifach to serve in office until the next annual meeting or until their successors are duly elected or appointed. Detailed results of the voting in respect of the election of directors are a","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESSA","BK4195","BK4211","BK4139","EPIX","INC"],"gpt_icon":0},{"id":"2510382062","title":"ESSA Pharma Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2510382062","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510382062?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 22:31","pubTimestamp":1739284300,"startTime":"0","endTime":"0","summary":"ESSA Pharma Inc reports results for the quarter ended December 31 - Earnings SummaryESSA Pharma Inc EPIX.OQ reported a quarterly adjusted loss of 19 cents per share for the quarter ended December 31, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nL8N3P21L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPIX"],"gpt_icon":0},{"id":"2510038353","title":"ESSA Pharma Q1 2025 GAAP EPS $(0.19) Misses $(0.12) Estimate, Cash $120.6M","url":"https://stock-news.laohu8.com/highlight/detail?id=2510038353","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510038353?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 20:40","pubTimestamp":1739277651,"startTime":"0","endTime":"0","summary":"ESSA Pharma (NASDAQ:EPIX) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 35.71 percent decrease over losses of $(0.14) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43620124/essa-pharma-q1-2025-gaap-eps-0-19-misses-0-12-estimate-cash-120-6m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPIX","ESSA"],"gpt_icon":0},{"id":"2510385435","title":"ESSA Pharma: Fiscal Q1 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2510385435","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510385435?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 20:17","pubTimestamp":1739276229,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia  — VANCOUVER, British Columbia  — ESSA Pharma Inc.  on Tuesday reported a loss of $8.5 million in its fiscal first quarter.On a per-share basis, the Vancouver, British Columbia-based company said it had a loss of 19 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essa-pharma-fiscal-q1-earnings-121709241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EPIX","ESSA"],"gpt_icon":0},{"id":"2510880058","title":"ESSA Pharma Inc - Terminates Masofaniten Clinical Trials, Exploring Strategic Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2510880058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510880058?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 20:05","pubTimestamp":1739275552,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P210H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EPIX","BK4139"],"gpt_icon":0},{"id":"2510565800","title":"ESSA Pharma Inc - Strategic Options Include Merger, Take-Over, Asset Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2510565800","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510565800?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 20:05","pubTimestamp":1739275552,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P210H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EPIX","BK4139"],"gpt_icon":0},{"id":"2510807069","title":"ESSA Pharma Q1 Operating Expenses USD -9.685 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2510807069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510807069?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 20:00","pubTimestamp":1739275205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nPLX316664:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EPIX"],"gpt_icon":0},{"id":"2510880033","title":"ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2510880033","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510880033?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 20:00","pubTimestamp":1739275200,"startTime":"0","endTime":"0","summary":"Company continues to explore and review strategic options focused on maximizing shareholder value. SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Feb. 11, 2025 /CNW/ - ESSA Pharma Inc.  , a pharmaceutical company that, prior to the discontinuation of its clinical trials and development programs, has been focused on developing novel therapies for the treatment of prostate cancer, today reported financial results for the fiscal first quarter ended December 31, 2024.\"Following our decision to terminate the clinical development of masofaniten, we have been evaluating and reviewing strategic options with a focus on maximizing shareholder value,\" said David Parkinson, MD, President and CEO of ESSA. \"We look forward to providing updates in the near future.\". Net Loss. ESSA recorded a net loss of $8.5 million for the first quarter ended December 31, 2024, compared to $6.0 million for the first quarter ended December 31, 2023. Investment and other income was $1.1 million for the first q","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essa-pharma-reports-financial-results-120000752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ESSA","BK4195","EPIX","BK4211"],"gpt_icon":0},{"id":"2509749430","title":"ESSA Pharma Inc  expected to post a loss of 18 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2509749430","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509749430?lang=en_us&edition=full_marsco","pubTime":"2025-02-07 22:09","pubTimestamp":1738937346,"startTime":"0","endTime":"0","summary":"ESSA Pharma Inc  expected to post a loss of18cents a share - Earnings Preview ESSA Pharma Inc EPIX.OQ EPIX.O is expected to show no change in quarterly revenue when it reports  results on February 11 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nL8N3OY1I0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPIX"],"gpt_icon":0},{"id":"2506151581","title":"ESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky LLP Before March 25, 2025 to Discuss Your Rights – EPIX","url":"https://stock-news.laohu8.com/highlight/detail?id=2506151581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506151581?lang=en_us&edition=full_marsco","pubTime":"2025-01-28 04:00","pubTimestamp":1738008011,"startTime":"0","endTime":"0","summary":"THE LAWSUIT: A class action securities lawsuit was filed against ESSA Pharma Inc. (EPIX) that seeks to recover losses of ESSA Pharma Inc. sharehold...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/essa-pharma-inc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-llp-before-march-25-2025-to-discuss-your-rights-epix?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/essa-pharma-inc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-llp-before-march-25-2025-to-discuss-your-rights-epix?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ESSA","BK4195","EPIX","BK4211","BK4139"],"gpt_icon":0},{"id":"2502986145","title":"BUZZ-ESSA Bancorp jumps on $214 mln buyout deal with CNB Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2502986145","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502986145?lang=en_us&edition=full_marsco","pubTime":"2025-01-10 22:11","pubTimestamp":1736518286,"startTime":"0","endTime":"0","summary":"BUZZ-ESSA Bancorp jumps on $214 mln buyout deal with CNB Financial** Shares of community lender ESSA Bancorp ESSA.O jump 9.5% to $20.39 premarket, while CNB Financial CCNE.O rises 1%** CCNE will buy smaller peer ESSA in a $214 mln all-stock deal, the companies say, creating a combined bank with roughly $8 bln in total assets** ESSA shareholders will receive 0.8547 shares of CCNE for each held, valuing ESSA at $20.61 per share based on CCNE's last close** Deal represents 10.6% premium to ESSA's last close and is expected to close in Q3 2025** Transaction bolsters CCNE's presence in greater Lehigh Valley and Scranton/Wilkes-Barre markets and is expected to boost bank's EPS by 35% in 2026** ESSA CEO Gary Olson will join CCNE's board and also have a strategic advisor role** ESSA's stock fell 2.6% in 2024 while CCNE jumped 10.1%   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nL4N3O610I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESSA","CCNE","BK4139","BK4195","BK4211","EPIX"],"gpt_icon":0},{"id":"2500953289","title":"3 Promising US Penny Stocks With Market Caps Under $80M","url":"https://stock-news.laohu8.com/highlight/detail?id=2500953289","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500953289?lang=en_us&edition=full_marsco","pubTime":"2025-01-02 04:08","pubTimestamp":1735762096,"startTime":"0","endTime":"0","summary":"As 2024 concludes, the U.S. stock market has experienced a mix of highs and lows, with major indices posting strong annual gains despite a weak finish. In the current market landscape, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their potential for value and growth. While the term \"penny stocks\" may seem outdated, these investments can still offer compelling opportunities for those looking beyond large-cap names, especially when backed by solid financials and promising prospects.Click here to see the full list of 735 stocks from our US Penny Stocks screener.Overview: ESSA Pharma Inc. is a clinical-stage pharmaceutical company developing small molecule drugs for prostate cancer treatment, with a market cap of $79.90 million.Overview: VerifyMe, Inc., along with its subsidiaries, offers traceability and customer support services using software and process technology, with a market cap of $8.29 million.Operations: The company's re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-us-penny-stocks-200816456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MLSS","BK4209","VRMEW","EPIX","VRME","BK4157","BABB"],"gpt_icon":0},{"id":"2493923070","title":"When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493923070","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493923070?lang=en_us&edition=full_marsco","pubTime":"2024-12-21 20:59","pubTimestamp":1734785959,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse ESSA Pharma Inc.'s  business as it appears the company may be on the cusp of a considerable accomplishment. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The US$71m market-cap company announced a latest loss of US$29m on 30 September 2024 for its most recent financial year result. Many investors are wondering about the rate at which ESSA Pharma will turn a profit, with the big question being “when will the company breakeven?”Below we will provide a high-level summary of the industry analysts’ expectations for the company.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essa-pharma-inc-nasdaq-epix-125919706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","TQQQ","TSYW.SI","ESSA","LU2210149790.SGD","BK4588","BK4211","BK4112","BK4585","MNQmain","LU2210150020.SGD","LU2095319765.USD","PSQ","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NVIW.SI","EPIX","QLD","SQQQ","IE00BKPKM429.USD","NDAQ","NQmain","BK4195","USJW.SI","BK4139","USAW.SI","IE00B3QW5Z07.USD","QID"],"gpt_icon":1},{"id":"2492923329","title":"ESSA Pharma Inc. Reports Strategic Shift Amid Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2492923329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492923329?lang=en_us&edition=full_marsco","pubTime":"2024-12-18 11:51","pubTimestamp":1734493874,"startTime":"0","endTime":"0","summary":"ESSA Pharma Inc. ( ($EPIX) ) has released its Q4 earnings. Here is a breakdown of the information ESSA Pharma Inc. presented to its investors. ESSA...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/essa-pharma-inc-reports-strategic-shift-amid-losses?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/essa-pharma-inc-reports-strategic-shift-amid-losses?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","EPIX","BK4195","BK4139","ESSA"],"gpt_icon":0},{"id":"2492954246","title":"ESSA Pharma Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2492954246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492954246?lang=en_us&edition=full_marsco","pubTime":"2024-12-17 21:13","pubTimestamp":1734441187,"startTime":"0","endTime":"0","summary":"ESSA Pharma Inc reports results for the quarter ended September 30 - Earnings SummaryESSA Pharma Inc EPIX.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter ended September 30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL8N3NI0XE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPIX"],"gpt_icon":0},{"id":"2492995988","title":"ESSA Pharma: Fiscal Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2492995988","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492995988?lang=en_us&edition=full_marsco","pubTime":"2024-12-17 20:17","pubTimestamp":1734437827,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia  — VANCOUVER, British Columbia  — ESSA Pharma Inc.  on Tuesday reported a loss of $6.4 million in its fiscal fourth quarter.The Vancouver, British Columbia-based company said it had a loss of 14 cents per share.The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.For the year, the company reported a loss of $28.5 million, or 64 cents per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essa-pharma-fiscal-q4-earnings-121707465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EPIX","ESSA"],"gpt_icon":0},{"id":"2492956846","title":"ESSA Pharma Q4 2024 GAAP EPS $(0.14) Beats $(0.21) Estimate, Cash Balance Of $103.71M","url":"https://stock-news.laohu8.com/highlight/detail?id=2492956846","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492956846?lang=en_us&edition=full_marsco","pubTime":"2024-12-17 20:12","pubTimestamp":1734437552,"startTime":"0","endTime":"0","summary":"ESSA Pharma Q4 2024 GAAP EPS $(0.14) Beats $(0.21) Estimate, Cash Balance Of $103.71M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/12/42526981/essa-pharma-q4-2024-gaap-eps-0-14-beats-0-21-estimate-cash-balance-of-103-71m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPIX","ESSA"],"gpt_icon":0},{"id":"2492955469","title":"ESSA Pharma Inc  Q4 Shr View $-0.20 -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2492955469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492955469?lang=en_us&edition=full_marsco","pubTime":"2024-12-17 20:00","pubTimestamp":1734436805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUABQZHMP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EPIX"],"gpt_icon":0},{"id":"2492148955","title":"ESSA Pharma Inc: Qtrly Loss per Share $0.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2492148955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492148955?lang=en_us&edition=full_marsco","pubTime":"2024-12-17 20:00","pubTimestamp":1734436805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUABQZHMP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EPIX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.essapharma.com","stockEarnings":[{"period":"1week","weight":-0.0313},{"period":"1month","weight":-0.0988},{"period":"3month","weight":-0.0373},{"period":"6month","weight":-0.7504},{"period":"1year","weight":-0.8285},{"period":"ytd","weight":-0.1341}],"compareEarnings":[{"period":"1week","weight":0.0257},{"period":"1month","weight":-0.0408},{"period":"3month","weight":-0.043},{"period":"6month","weight":0.0055},{"period":"1year","weight":0.1071},{"period":"ytd","weight":-0.0181}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. The company develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. It has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.102519},{"month":2,"riseRate":0.4,"avgChangeRate":0.024211},{"month":3,"riseRate":0.4,"avgChangeRate":0.006842},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.117263},{"month":5,"riseRate":0.666667,"avgChangeRate":0.039367},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.149047},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.07031},{"month":8,"riseRate":0.5,"avgChangeRate":-0.092663},{"month":9,"riseRate":0.6,"avgChangeRate":-0.004582},{"month":10,"riseRate":0.5,"avgChangeRate":0.146396},{"month":11,"riseRate":0.6,"avgChangeRate":-0.015736},{"month":12,"riseRate":0.4,"avgChangeRate":0.032688}],"exchange":"NASDAQ","name":"ESSA Pharma","nameEN":"ESSA Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ESSA Pharma(EPIX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ESSA Pharma(EPIX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ESSA Pharma,EPIX,ESSA Pharma股票,ESSA Pharma股票老虎,ESSA Pharma股票老虎国际,ESSA Pharma行情,ESSA Pharma股票行情,ESSA Pharma股价,ESSA Pharma股市,ESSA Pharma股票价格,ESSA Pharma股票交易,ESSA Pharma股票购买,ESSA Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ESSA Pharma(EPIX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ESSA Pharma(EPIX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}